We assessed whether montelukast or formoterol provides additive effects to asthmatics not controlled on inhaled corticosteroids , by studying patients who were considered to be genetically susceptible to beta2-receptor down regulation and subsensitivity , and who expressed the homozygous glycine-16 beta2-receptor genotype .
